Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00812240
Title A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AB Science
Indications

gastrointestinal stromal tumor

Therapies

Masitinib

Imatinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST